Search

Brain tumors are the most common solid tumors in the pediatric population. Pediatric neuro-oncology has changed tremendously during the past decade owing to ongoing genomic advances. The diagnosis, prognosis, and treatment of pediatric brain tumors are now highly reliant on the genetic profile and histopathologic features of the tumor rather than the histopathologic features alone, which previously were the reference standard. The clinical information expected to be gleaned from radiologic interpretations also has evolved. Imaging is now expected to not only lead to a relevant short differential diagnosis but in certain instances also aid in predicting the specific tumor and subtype and possibly the prognosis. These processes fall under the umbrella of radiogenomics. Therefore, to continue to actively participate in patient care and/or radiogenomic research, it is important that radiologists have a basic understanding of the molecular mechanisms of common pediatric central nervous system tumors. The genetic features of pediatric low-grade gliomas, high-grade gliomas, medulloblastomas, and ependymomas are reviewed; differences between pediatric and adult gliomas are highlighted; and the critical oncogenic pathways of each tumor group are described. The role of the mitogen-activated protein kinase pathway in pediatric low-grade gliomas and of histone mutations as epigenetic regulators in pediatric high-grade gliomas is emphasized. In addition, the oncogenic drivers responsible for medulloblastoma, the classification of ependymomas, and the associated imaging correlations and clinical implications are discussed. ©RSNA, 2018. more...

To retrospectively determine and compare the sensitivity and specificity of unenhanced and contrast material-enhanced computed tomography (CT) (reference standard) in the diagnosis of brain abnormalities and to evaluate any change in diagnosis that resulted from the contrast-enhanced study.This study was approved by the local research ethics board; the requirement for informed consent was waived. The authors reviewed the unenhanced and contrast-enhanced CT scans of the brain obtained in 353 children for indications other than trauma. There were 196 boys and 157 girls aged 0 months to 17.8 years. Scans were read independently by two pediatric neuroradiologists who were blinded to clinical information. The diagnosis for each scan was recorded according to the anatomic section (supratentorial, infratentorial, ventricles, and skull). The final diagnosis was classified as normal, abnormal, or equivocal. kappa Statistics, with 95% confidence intervals, were reported, and the sensitivity, specificity, positive predictive value, and negative predictive value were calculated.Interreader agreement for different anatomic regions varied between good (kappa coefficient, 0.63) and very good (kappa coefficient, 0.88) for unenhanced and contrast-enhanced scans. Sensitivity, specificity, positive predictive value, and negative predictive value for unenhanced scans were 97%, 89%, 87%, and 97%, respectively. The use of contrast material led to a change in the original normal or equivocal diagnosis to an abnormal diagnosis for only five (2.7%) of the 183 normal unenhanced scans.Unenhanced CT of developing brains has high sensitivity and specificity in the diagnosis of pathologic findings. The use of intravenous contrast material after unenhanced CT of the brain in children did not change the diagnosis frequently. more...